Workflow
百克生物(688276) - 2024 Q1 - 季度财报
BCHTBCHT(SH:688276)2024-04-19 07:46

Revenue and Profitability - The company's revenue for Q1 2024 reached ¥270,288,441.14, representing a year-over-year increase of 50.64%[4] - Net profit attributable to shareholders was ¥60,565,065.43, showing a significant increase of 229.50% compared to the same period last year[4] - The basic earnings per share (EPS) for the quarter was ¥0.15, reflecting a 275.00% increase year-over-year[4] - Total revenue for Q1 2024 reached ¥270,288,441.14, a significant increase of 50.5% compared to ¥179,431,529.21 in Q1 2023[16] - The company's net profit for Q1 2024 reached CNY 60,565,065.43, a significant increase from CNY 18,381,036.97 in Q1 2023, representing a growth of approximately 229.5%[18] - The total comprehensive income for Q1 2024 was CNY 52,979,886.88, compared to CNY 17,034,520.01 in Q1 2023, representing an increase of approximately 210.5%[19] - The net profit for Q1 2024 was ¥62,095,669.48, up from ¥27,700,652.65 in Q1 2023, representing a growth of 124.5%[27] Expenses and Costs - Total operating costs for Q1 2024 were ¥210,708,743.52, up from ¥160,401,552.49 in Q1 2023, reflecting a year-over-year increase of 31.4%[16] - Operating expenses increased to CNY 284,261,703.59 in Q1 2024 from CNY 222,250,361.42 in Q1 2023, which is an increase of about 27.9%[21] - Research and development (R&D) expenses totaled ¥46,940,335.50, accounting for 17.37% of revenue, which is a decrease of 5.48 percentage points from the previous year[6] - Research and development expenses increased to CNY 46,940,335.50 in Q1 2024, up from CNY 33,403,636.31 in Q1 2023, reflecting a growth of about 40.5%[18] Cash Flow and Liquidity - The company reported a net cash flow from operating activities of -¥7,933,515.62, indicating a cash outflow during the quarter[4] - The company reported a total cash inflow from operating activities of CNY 276,328,187.97 in Q1 2024, compared to CNY 217,664,822.46 in Q1 2023, marking an increase of about 27%[21] - The company incurred a net cash outflow from operating activities of CNY 7,933,515.62 in Q1 2024, compared to a net outflow of CNY 4,585,538.96 in Q1 2023[21] - The company experienced a net cash decrease of CNY 49,671,277.68 in Q1 2024, compared to a decrease of CNY 71,036,737.74 in Q1 2023, showing a 30% improvement[29] Assets and Liabilities - Total assets at the end of the quarter were ¥5,090,699,597.65, a slight increase of 0.88% from the end of the previous year[6] - Current assets as of March 31, 2024, totaled ¥2,264,056,252.59, slightly up from ¥2,244,613,929.98 at the end of 2023[14] - Total liabilities decreased to ¥1,011,361,789.38 from ¥1,025,876,086.75, a reduction of 1.4%[16] - The total equity as of March 31, 2024, was ¥4,378,444,683.82, up from ¥4,317,937,847.49 at the end of 2023, an increase of 1.4%[25] Shareholder Information - The company has a total of 8,338 shareholders, with the largest shareholder holding 41.54% of the shares[10] - Shareholders' equity increased to ¥4,079,337,808.27 from ¥4,020,361,575.99, showing a growth of 1.5%[16] Other Financial Metrics - The weighted average return on equity (ROE) was 1.50%, an increase of 0.99 percentage points compared to the previous year[6] - Non-recurring gains and losses amounted to ¥761,098.18 for the quarter, primarily from government subsidies[7] - The company reported a decrease in other comprehensive income, with a net amount of -¥7,585,178.55 for Q1 2024 compared to -¥1,346,516.96 in Q1 2023[27] - The company has not yet adopted new accounting standards for the current year, which may impact future financial reporting[29]